• Latest Posts

UK Biotech Closes €50M Series A for GPCR Drug Discovery

More News! 7 Oct 2019

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

LAB282 Awards Second Funding Round to 5 Academic Projects at Oxford

Evotec chooses Oxford as Proving Ground for Academia-Industry Bridge

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

Neil Woodford’s Latest €25M UK Biotech pay-out is to AMO Pharma


It’s raining cash, Woodford invested more than 75% of its mega €1.1Bn Biotech fund